Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 110 member C (FAM110C) is a cytoplasmic protein primarily involved in regulating the organization of the microtubule cytoskeleton and cellular processes related to migration and spreading[1][3][5]. FAM110C binds alpha-tubulin and is located in the cell cortex, associating with centrosomes during interphase and with microtubules during mitosis[2][6]. It is transiently upregulated during the periovulatory period in granulosa cells, where its overexpression leads to G1 cell cycle arrest but does not affect steroidogenic function, suggesting a role in granulosa cell differentiation rather than steroid hormone production[2]. FAM110C also interacts with AKT1, and depletion of the protein impairs integrin-mediated formation of filopodia and cell migration, likely involving PI3K/AKT1 signaling pathways[1][5]. FAM110C is not a therapeutic target, but it is of interest in cell biology and developmental studies for its role in cell cycle regulation and differentiation.
No drug mechanisms of action are established for this protein, as it is not pharmacologically targeted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 110 member C (FAM110C).